The 2023 World-Class Speaker Faculty Included:

Abbas El Sahili

Chief Executive Officer

Singzyme

Adam Palmer

Assistant Professor, Pharmacology

UCN

Adam Taylor

Senior Scientist

Defence Science & Technology Laboratory

Alice Yam

Executive Director, Preclinical Portfolio

Sutro Biopharma

Allan W Ader

Managing Director

SafeBridge Consultants, Inc.

Aming Zhang

Head, Analytical Development & QC

Pyxis Oncology

Amita Patel

Associate Principal Scientist

Merck & Co

Andrea Hernandez Rojas

Scientist & Group Lead, In Vitro Biology, ADC Therapeutic Development

Zymeworks

Andrea Ngai

Senior Manager - Bioanalysis & Biomarkers

Amador Bioscience

Andreas Pahl

Chief Scientific Officer

Heidelberg Pharma

Aniko Palfi

Director

Heidelberg Pharma Research

Anita Kulukian

Principal Scientist

Seagen

Benjamin Oshrine

Medical Director, Clinical Development

ImmunoGen

Bertand Cottineau

Research & Development, Group Head

Axplora

Bingquan Wang

Senior Director

WuXi XDC CMC Management

Brandon Mapes

Senior Computational Biologist

Tempus

Changshou Gao

Senior Vice President & Chief Technology Officer

Innovent Biologics

Christian Marsolais

Senior Vice President & Chief Medical Officer

Theratechnologies

Christine Köhler

Head of Antibody Engineering

VERAXA Biotech

Christopher Gillespie

Director, External Manufacturing

Merck & Co.

Christopher Marvin

Principal Research Scientist II

AbbVie

Chunze Li

Head, Oncology Clinical Pharmacology

Genentech

Conor Barry

Head of Development

Piramal Pharma Solutions

David Bramhill

President & Founder

Bramhill Biological Consulting

Devendra Srivastava

Director, Protein Sciences

OmniAb

Dharti Kothari

Associate Director - External Manufacturing, Chemistry, Manufacturing, Controls, Drug Substance & Drug Product

Bolt Biotherapeutics

Dolon Maji

Senior Scientist II, Drug Metabolism & Pharmacokinetics

AbbVie

Douglas Watson

Director, Regulatory Affairs CMC Biologics

Merck & Co

Drew Tack

Senior Scientist

Absci

Earl Albone

Executive Director, Biochemistry & Bioanalytical Development

Eisai

Eric Lacoste

Head of ADC Conjugation Development

Sanofi

Eric Miller

Senior Director, Analytical

Abzena

Eshita Khera

Principal Scientist I

Novartis

Esohe Idusogie

Head of Process Quality & CMC Analytical

ADC Therapeutics

Esther Biemans

Senior Scientist

Ardena

Floris van Delft

Founder and Chief Scientific Officer

Synaffix

Frank Comer

Director, Tumor Targeted Delivery, Early Oncology Discovery

AstraZeneca

Gail Lewis

Senior Principal Scientist

Genentech

Ganesh Vissvesvaran

Executive Director, MSAT

Sutro Biopharma

Gang Yin

Vice President, Protein Biochemistry

Sutro Biopharma

Gerold Meinhardt

Vice President - Asset & Portfolio Management

Daiichi Sankyo

Greg Thurber

Associate Chair

University of Michigan

Gregory Adams

Chief Scientific Officer

Elucidia Oncology

Guifeng Jiang

Head of Analytical Development

Bolt Biotherapeutics

Guitao Wang

President of R&D Institute

Coherent Biopharma

Guoxiang Shen

Executive Director, Head of Clinical Pharmacology

BioAtla

Hannes Landmann

Product and Crossflow Systems Manager

Sartorius

Haowei Song

Principal Scientist in Novel Modalities R&D

MilliporeSigma

Helena Kiefel

Director, Pharmacology

Sutro Biopharma

Hsing-Mao Chu

Vice President, R&D

Immunwork

Hui Zhao

Senior Director, Translational Biology

Exelixis

Jake Morris

Senior Account Manager & ADC Insights Lead

Beacon Targeted Therapies

James Palacino

Vice President & Head of Biology

Orum Therapeutics

James Purcell

Research Fellow

AbbVie

Jan Schnitzer

Founder, Director & Chief Executive Officer

PRISM Therapeutics

Jay Harper

Director, Early Oncology

AstraZeneca

Jay Mettetal

Senior Director, Oncology Bioscience

Astrazenica

Jia He

Senior Research Analyst

Beacon Targeted Therapies

Jian Chen

Director, Translational Research & Preclinical Development

BioAtla

Joe Zhao

Vice President

Nona Biosciences

Johanna Midelet

Bioconjugation Manager

Abzena

John Lambert

Independent Consultant

Attager Consulting

Juhani Saarinen

Chief Executive Officer

Glykos

Julie Beaudet

CMC Staff Scientist

Regeneron Pharmaceuticals

Julien Dugal-Tessier

Vice President, Research & Development

NJ Bio, Inc.

Juma Bridgewater

Principal Scientist

Amgen

Jun Hasewga

Scientist

Daiichi Sankyo

Jutta Deckert

Executive Director, Translational R&D

Iksuda Therapeutics

Kati Räsänen

Director, Pharmacology

SOTIO Biotech

Krishna Bajjuri

Senior Director, Chemistry

Sutro Biopharma

Kristin Bedard

Vice President, Biologics

Loxo Oncology

Lara McGrath

Director Translational Medicine

AstraZeneca

Laura Guo

Chief Business Officer

Adcoris

Laurence Madera

Senior Scientist, In Vitro Biology, ADC Therapeutic Development

Zymeworks

Leo Xuebin Liu

Senior Vice President, Pre-Clinical R&D

Inxmed

Li Wan

Chief Development Officer

Genequantum Healthcare

Li-Ming Liang

VP of Business Development

Mycenax

Lieza Danan

Co-Founder and CEO

LiVeritas Biosciences, Inc.

Lisa McDermott

Director, Process & Analytical Development

MilliporeSigma

Luke Masterson

Chemistry Group Leader

AstraZeneca

Manoj Chiney

Director, Clinical Pharmacology

Gilead Sciences

Marcia Belvin

Senior Vice President, Head of Research

CytomX Therapeutics

Maria Elena Guadagno

Technical Operations & Business Executive Director

BSP Pharmaceuticals

Martina McDermott

Adjunct Assistant Professor

University of California, Los Angeles

Mary Ramisetty

Senior Scientist Group Lead Process & Analytical Development

MilliporeSigma

Matt Sender

Associate Director

GSK

Meijuan Li

Vice President & Head of Biostatistics & Translational Science & Oncology

Eisai

Melanie Derde

Bioconjugation Analytical Manager

Axplora

Melanie Frigault

Vice President Translational Medicine

Vincerx Pharma

Mike Liao

Global Clinical Oncology Lead

Genentech

Mingyan Cao

Associate Director

GlaxoSmithKline

Naresh Jain, Ph.D.

President & Chief Executive Officer

NJ Bio, Inc.

Nathan Ihle

Senior Vice President

Bolt Biotherapeutics

Patrick Groothuis

Principal Scientist

Byondis

Patrick Zweidler-McKay

Executive Medical Director

ImmunoGen

Paul Song

Chief Scientific Officer

Genequantum Healthcare

Penelope Drake

Head of R&D, Bioconjugates

Catalent Pharma Solutions

Radhika Balasubramani

Director, Technical Product Lead, Antibody Drug Conjugates

Merck & Co

Rakesh Dixit

Independent Consultant

Ramana Dopplapudi

Vice President

Avidity Biosciences

Raphael Frey

Team Lead - Early Development Bioconjugates

Lonza

Robert Huang

Founder & Chief Executive Officer

Coherent Biopharma

Robert Lawrence

Principal Scientist

Seagen

Robert Lutz

Chief Scientific Officer

Iksuda Therapeutics

Ronald Elgersma

Project Manager

Byondis

Ross Bemowski

Associate Director, API Research and Development

MilliporeSigma

Rui Fang

Associate Principal Scientist

Merck & Co.

Sam Bandel

Associate Director, External Manufacturing

Gilead Sciences

Samuele Cazzamalli

Head of Small Molecule Therapeutics

Philochem

Sarah Owen

Senior Scientist

Seagen

Sarah-Jane Neuberth

Group Leader In Vivo Biology

Heidelberg Pharma

Shalom Goldberg

Senior Principal Scientist

Johnson & Johnson

Shawn Zhang

Chief Scientific Officer

Ambrx

Shiyue Zhou

Senior Scientist

AbbVie

Shumin Liu

Chief Executive Officer

Shenzhen Enduring

Shunsuke Ozaki

Principal Scientist

Eisai

Sofia Genta

Medical Oncology Clinical Fellow

Princess Margaret Cancer Centre

Srinath Thirumalairajan

Director of Process Engineering

Seagen

Stephan Slocum

Director

LegoChem Biosciences

Susan Solomon

Head of Quality Control

ADC Therapeutics

Tae Kyo Park

Chief Executive Officer

IntoCell

Taruna Arora

Vice President, Biotherapeutics

Bristol-Myers Squibb

Thomas Kralj

Scientist II

Amador Biosciences

Thomas Nittoli

Senior DIrector

Regeneron

Tomohiro Fujii

ADC Researcher

Ajinomoto

Vitor Sousa

Director - Business Development

Cerbios-Pharma

Vivian Trang

Principal Scientist

Seagen

Weian Zhao

CEO

Aureka Biotechnologies

Weilong Zhao

Team Lead, Computational Oncology

AbbVie

Weining Hu

Assistant Vice President, CMC Regulatory Affairs

Merck & Co

Xavier Pujol, PhD

Chief Scientific Officer, CDMO New Business Development

North America Farmhispania Group

Xi Zhao

Senior Principal Research Scientist, Computational Oncology Genomic Research Center

AbbVie

Xuhong Cheng

Executive Director, Regulatory CMC

Actinium Pharma

Ying Buechler

Chief Technology Officer

Ambrx

Yiqing Feng

Vice President, Research

Eli Lilly

Yuan Cheng

Senior Principal Scientist

Amgen

Yuhua Hu

Executive Director

WuXi XDC CMC Management

Yuki Matsuno

Researcher

NOF Corporation

Ziping Wei

Chief Executive Officer

Bliss Bio